A milestone for patients with blood cancers: Today, FDA approved the first Treg cell-based immunotherapy to improve chronic GVHD-free survival following hematopoietic stem cell transplantation in adults. Find out more: https://t.co/bNY4G9H0rm
KLF2 expression in IgG plasma cells at their induction site regulates the migration program, say Wataru Ise, Takuya Koike, Tomohiro Kurosaki @osaka_univ_e and colleagues: https://t.co/UPtxzvJo4T
#LymphocyteBiology
Online now: Transcription factor Ikzf1 associates with Foxp3 to repress gene expression in Treg cells and limit autoimmunity and anti-tumor immunity https://t.co/LFCRvqh8DW